180 related articles for article (PubMed ID: 38308969)
21. Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease.
Kotlyarov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563159
[TBL] [Abstract][Full Text] [Related]
22. Short-chain fatty acids (SCFAs) from gastrointestinal disorders, metabolism, epigenetics, central nervous system to cancer - A mini-review.
Abdelhalim KA
Chem Biol Interact; 2024 Jan; 388():110851. PubMed ID: 38145797
[TBL] [Abstract][Full Text] [Related]
23. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
[TBL] [Abstract][Full Text] [Related]
24. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
Sivaprakasam S; Prasad PD; Singh N
Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
[TBL] [Abstract][Full Text] [Related]
25. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases.
Stec A; Sikora M; Maciejewska M; Paralusz-Stec K; Michalska M; Sikorska E; Rudnicka L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834904
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
[TBL] [Abstract][Full Text] [Related]
27. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
Agus A; Clément K; Sokol H
Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
[TBL] [Abstract][Full Text] [Related]
29. Gut microbiota-derived short-chain fatty acids and kidney diseases.
Li L; Ma L; Fu P
Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
[TBL] [Abstract][Full Text] [Related]
30. Microbial metabolites are involved in tumorigenesis and development by regulating immune responses.
Liu J; Tian R; Sun C; Guo Y; Dong L; Li Y; Song X
Front Immunol; 2023; 14():1290414. PubMed ID: 38169949
[TBL] [Abstract][Full Text] [Related]
31. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
[TBL] [Abstract][Full Text] [Related]
32. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
33. The emerging role of microbiota-derived short-chain fatty acids in immunometabolism.
Abdalkareem Jasim S; Jade Catalan Opulencia M; Alexis Ramírez-Coronel A; Kamal Abdelbasset W; Hasan Abed M; Markov A; Raheem Lateef Al-Awsi G; Azamatovich Shamsiev J; Thaeer Hammid A; Nader Shalaby M; Karampoor S; Mirzaei R
Int Immunopharmacol; 2022 Sep; 110():108983. PubMed ID: 35750016
[TBL] [Abstract][Full Text] [Related]
34. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
Massey W; Brown JM
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
[TBL] [Abstract][Full Text] [Related]
35. Dietary butyrate suppresses inflammation through modulating gut microbiota in high-fat diet-fed mice.
Zhai S; Qin S; Li L; Zhu L; Zou Z; Wang L
FEMS Microbiol Lett; 2019 Jul; 366(13):. PubMed ID: 31295342
[TBL] [Abstract][Full Text] [Related]
36. Interplay of gut microbiome, fatty acids, and the endocannabinoid system in regulating development, progression, immunomodulation, and chemoresistance of cancer.
Nandi SK; Basu S; Bhattacharjya A; Dey Ghosh R; Bose CK; Mukhopadhyay S; Bhattacharya R
Nutrition; 2022; 103-104():111787. PubMed ID: 36055123
[TBL] [Abstract][Full Text] [Related]
37. The bridge of the gut-joint axis: Gut microbial metabolites in rheumatoid arthritis.
Xu X; Wang M; Wang Z; Chen Q; Chen X; Xu Y; Dai M; Wu B; Li Y
Front Immunol; 2022; 13():1007610. PubMed ID: 36275747
[TBL] [Abstract][Full Text] [Related]
38. Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy.
Luu M; Monning H; Visekruna A
Front Immunol; 2020; 11():1225. PubMed ID: 32612610
[TBL] [Abstract][Full Text] [Related]
39. Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: Focused on host defense peptides.
Liu T; Sun Z; Yang Z; Qiao X
Biomed Pharmacother; 2023 Jun; 162():114586. PubMed ID: 36989711
[TBL] [Abstract][Full Text] [Related]
40. Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy.
Rangan P; Mondino A
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35882448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
